PharmaCorp Rx Inc.
PCRX.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -281.00K | -429.90K | -757.30K | -1.46M | -819.70K |
| Total Depreciation and Amortization | 459.30K | 339.40K | 208.80K | 72.00K | 16.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 89.70K | 99.70K | 113.80K | 540.50K | 3.00K |
| Change in Net Operating Assets | 12.00K | 290.90K | 504.10K | -93.80K | 271.10K |
| Cash from Operations | 280.10K | 300.10K | 69.40K | -939.90K | -529.20K |
| Capital Expenditure | -1.55M | -23.70K | -5.00K | -5.00K | -5.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -12.88M | -12.08M | -12.08M | -1.47M | 58.60K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -14.43M | -12.10M | -12.09M | -1.47M | 53.60K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -193.00K | -157.80K | -107.10K | -56.00K | -15.30K |
| Issuance of Common Stock | 7.64M | 27.49M | 27.49M | 27.49M | 19.86M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5.46M | 20.00M | 20.03M | 20.07M | 14.50M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.69M | 8.19M | 8.02M | 17.65M | 14.02M |